Loading…
Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide
Previous investigations of the potential of metal–organic compounds as inhibitors of human immunodeficiency virus type I protease (HIV-1 PR) showed that the copper(II) complex diaqua [bis(2-pyridylcarbonyl)amido] copper(II) nitrate dihydrate and the complex bis[ N2-(2,3,6-trimethoxybenzyl)-4-2-pyrid...
Saved in:
Published in: | Journal of inorganic biochemistry 2001-09, Vol.86 (2), p.547-554 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c361t-39164e634dc2d2c43795c59423368a8f40ec9b57d0b97e667f7a7b5b7e4dbe173 |
---|---|
cites | |
container_end_page | 554 |
container_issue | 2 |
container_start_page | 547 |
container_title | Journal of inorganic biochemistry |
container_volume | 86 |
creator | Lebon, Florence Ledecq, Marie Dieu, Marc Demazy, Catherine Remacle, José Lapouyade, René Kahn, Olivier Durant, François |
description | Previous investigations of the potential of metal–organic compounds as inhibitors of human immunodeficiency virus type I protease (HIV-1 PR) showed that the copper(II) complex diaqua [bis(2-pyridylcarbonyl)amido] copper(II) nitrate dihydrate and the complex bis[
N2-(2,3,6-trimethoxybenzyl)-4-2-pyridinecarboxamide] copper(II) behaved as inhibitors of HIV-1 PR. In a search for similar readily accessible ligands, we synthesised and studied the structural properties of
N2-(2-pyridylmethyl)-2-pyridinecarboxamide (L) copper(II) complexes. Three different crystal structures were obtained. Two were found to contain ligand L simultaneously in a tridentate and bidentate conformation [Cu(L
triL
bi)]. The other contained two symmetry-related ligands, coordinated through the pyridine nitrogen and the amide oxygen atoms [Cu(L
bi)
2]. A search of the Cambridge Structural Database indicated that L
tri resulting from nitrogen bound amide hydrogen metal substitution is favoured over chelation through the amide oxygen atom. In our case, we calculated that the conformation of L
tri is 11 kcal/mol more favourable than that of L
bi. ESI-MS experiments showed that the Cu(L
bi)
2 structure could not be observed in solution, while Cu(L
triL
bi)-related complexes were indeed present. The lack of protease inhibition of the pyridine carboxamide copper(II) complexes was explained by the fact that the Cu(L
biL
tri) complex could not fit into the HIV-1 active site. |
doi_str_mv | 10.1016/S0162-0134(01)00219-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71188438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0162013401002197</els_id><sourcerecordid>71188438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-39164e634dc2d2c43795c59423368a8f40ec9b57d0b97e667f7a7b5b7e4dbe173</originalsourceid><addsrcrecordid>eNqFkMtOxCAUhonROOPoI2hmZWYWKBQK7coY42USowt1TSicRrQ3oTXTt7edmejSzQEO3-EPH0KnlFxQQsXly1AiTCjjC0KXhEQ0xXIPTWkiGWaM8300_UUm6CiED0JIHHN5iCaUxkKwSEzR50tfte8QXJjrys5D6zvTdl4Xw1EX_div8_lAzE3dNOAXq9Vy2JZNAWvY3D1FeBHhpvfO9kUJ7XtfLPGu4Sow2mf1WpfOwjE6yHUR4GS3ztDb3e3rzQN-fL5f3Vw_YsMEbTFLqeAgGLcmspHhTKaxiVMeMSYSneScgEmzWFqSpRKEkLnUMoszCdxmQCWbofPtu42vvzoIrSpdMFAUuoK6C0pSmiScJQMYb0Hj6xA85KrxrtS-V5So0bLaWFajwqGojWU1BpztArqsBPs3tdM6AFdbAIZvfjvwKhgHlQHrPJhW2dr9E_EDVguMXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71188438</pqid></control><display><type>article</type><title>Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide</title><source>ScienceDirect Freedom Collection</source><creator>Lebon, Florence ; Ledecq, Marie ; Dieu, Marc ; Demazy, Catherine ; Remacle, José ; Lapouyade, René ; Kahn, Olivier ; Durant, François</creator><creatorcontrib>Lebon, Florence ; Ledecq, Marie ; Dieu, Marc ; Demazy, Catherine ; Remacle, José ; Lapouyade, René ; Kahn, Olivier ; Durant, François</creatorcontrib><description>Previous investigations of the potential of metal–organic compounds as inhibitors of human immunodeficiency virus type I protease (HIV-1 PR) showed that the copper(II) complex diaqua [bis(2-pyridylcarbonyl)amido] copper(II) nitrate dihydrate and the complex bis[
N2-(2,3,6-trimethoxybenzyl)-4-2-pyridinecarboxamide] copper(II) behaved as inhibitors of HIV-1 PR. In a search for similar readily accessible ligands, we synthesised and studied the structural properties of
N2-(2-pyridylmethyl)-2-pyridinecarboxamide (L) copper(II) complexes. Three different crystal structures were obtained. Two were found to contain ligand L simultaneously in a tridentate and bidentate conformation [Cu(L
triL
bi)]. The other contained two symmetry-related ligands, coordinated through the pyridine nitrogen and the amide oxygen atoms [Cu(L
bi)
2]. A search of the Cambridge Structural Database indicated that L
tri resulting from nitrogen bound amide hydrogen metal substitution is favoured over chelation through the amide oxygen atom. In our case, we calculated that the conformation of L
tri is 11 kcal/mol more favourable than that of L
bi. ESI-MS experiments showed that the Cu(L
bi)
2 structure could not be observed in solution, while Cu(L
triL
bi)-related complexes were indeed present. The lack of protease inhibition of the pyridine carboxamide copper(II) complexes was explained by the fact that the Cu(L
biL
tri) complex could not fit into the HIV-1 active site.</description><identifier>ISSN: 0162-0134</identifier><identifier>EISSN: 1873-3344</identifier><identifier>DOI: 10.1016/S0162-0134(01)00219-7</identifier><identifier>PMID: 11566326</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Catalytic Domain ; Copper - chemistry ; Crystallography, X-Ray ; Drug Design ; ESI-MS ; HIV Protease - chemistry ; HIV Protease Inhibitors - chemical synthesis ; HIV Protease Inhibitors - chemistry ; HIV Protease Inhibitors - pharmacology ; HIV-1 PR ; In Vitro Techniques ; Inhibitors ; Metal–organic complexes ; Models, Molecular ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Pyridines - chemical synthesis ; Pyridines - chemistry ; Pyridines - pharmacology ; Spectrometry, Mass, Electrospray Ionization</subject><ispartof>Journal of inorganic biochemistry, 2001-09, Vol.86 (2), p.547-554</ispartof><rights>2001 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-39164e634dc2d2c43795c59423368a8f40ec9b57d0b97e667f7a7b5b7e4dbe173</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11566326$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lebon, Florence</creatorcontrib><creatorcontrib>Ledecq, Marie</creatorcontrib><creatorcontrib>Dieu, Marc</creatorcontrib><creatorcontrib>Demazy, Catherine</creatorcontrib><creatorcontrib>Remacle, José</creatorcontrib><creatorcontrib>Lapouyade, René</creatorcontrib><creatorcontrib>Kahn, Olivier</creatorcontrib><creatorcontrib>Durant, François</creatorcontrib><title>Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide</title><title>Journal of inorganic biochemistry</title><addtitle>J Inorg Biochem</addtitle><description>Previous investigations of the potential of metal–organic compounds as inhibitors of human immunodeficiency virus type I protease (HIV-1 PR) showed that the copper(II) complex diaqua [bis(2-pyridylcarbonyl)amido] copper(II) nitrate dihydrate and the complex bis[
N2-(2,3,6-trimethoxybenzyl)-4-2-pyridinecarboxamide] copper(II) behaved as inhibitors of HIV-1 PR. In a search for similar readily accessible ligands, we synthesised and studied the structural properties of
N2-(2-pyridylmethyl)-2-pyridinecarboxamide (L) copper(II) complexes. Three different crystal structures were obtained. Two were found to contain ligand L simultaneously in a tridentate and bidentate conformation [Cu(L
triL
bi)]. The other contained two symmetry-related ligands, coordinated through the pyridine nitrogen and the amide oxygen atoms [Cu(L
bi)
2]. A search of the Cambridge Structural Database indicated that L
tri resulting from nitrogen bound amide hydrogen metal substitution is favoured over chelation through the amide oxygen atom. In our case, we calculated that the conformation of L
tri is 11 kcal/mol more favourable than that of L
bi. ESI-MS experiments showed that the Cu(L
bi)
2 structure could not be observed in solution, while Cu(L
triL
bi)-related complexes were indeed present. The lack of protease inhibition of the pyridine carboxamide copper(II) complexes was explained by the fact that the Cu(L
biL
tri) complex could not fit into the HIV-1 active site.</description><subject>Catalytic Domain</subject><subject>Copper - chemistry</subject><subject>Crystallography, X-Ray</subject><subject>Drug Design</subject><subject>ESI-MS</subject><subject>HIV Protease - chemistry</subject><subject>HIV Protease Inhibitors - chemical synthesis</subject><subject>HIV Protease Inhibitors - chemistry</subject><subject>HIV Protease Inhibitors - pharmacology</subject><subject>HIV-1 PR</subject><subject>In Vitro Techniques</subject><subject>Inhibitors</subject><subject>Metal–organic complexes</subject><subject>Models, Molecular</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Pyridines - chemical synthesis</subject><subject>Pyridines - chemistry</subject><subject>Pyridines - pharmacology</subject><subject>Spectrometry, Mass, Electrospray Ionization</subject><issn>0162-0134</issn><issn>1873-3344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOxCAUhonROOPoI2hmZWYWKBQK7coY42USowt1TSicRrQ3oTXTt7edmejSzQEO3-EPH0KnlFxQQsXly1AiTCjjC0KXhEQ0xXIPTWkiGWaM8300_UUm6CiED0JIHHN5iCaUxkKwSEzR50tfte8QXJjrys5D6zvTdl4Xw1EX_div8_lAzE3dNOAXq9Vy2JZNAWvY3D1FeBHhpvfO9kUJ7XtfLPGu4Sow2mf1WpfOwjE6yHUR4GS3ztDb3e3rzQN-fL5f3Vw_YsMEbTFLqeAgGLcmspHhTKaxiVMeMSYSneScgEmzWFqSpRKEkLnUMoszCdxmQCWbofPtu42vvzoIrSpdMFAUuoK6C0pSmiScJQMYb0Hj6xA85KrxrtS-V5So0bLaWFajwqGojWU1BpztArqsBPs3tdM6AFdbAIZvfjvwKhgHlQHrPJhW2dr9E_EDVguMXg</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Lebon, Florence</creator><creator>Ledecq, Marie</creator><creator>Dieu, Marc</creator><creator>Demazy, Catherine</creator><creator>Remacle, José</creator><creator>Lapouyade, René</creator><creator>Kahn, Olivier</creator><creator>Durant, François</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide</title><author>Lebon, Florence ; Ledecq, Marie ; Dieu, Marc ; Demazy, Catherine ; Remacle, José ; Lapouyade, René ; Kahn, Olivier ; Durant, François</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-39164e634dc2d2c43795c59423368a8f40ec9b57d0b97e667f7a7b5b7e4dbe173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Catalytic Domain</topic><topic>Copper - chemistry</topic><topic>Crystallography, X-Ray</topic><topic>Drug Design</topic><topic>ESI-MS</topic><topic>HIV Protease - chemistry</topic><topic>HIV Protease Inhibitors - chemical synthesis</topic><topic>HIV Protease Inhibitors - chemistry</topic><topic>HIV Protease Inhibitors - pharmacology</topic><topic>HIV-1 PR</topic><topic>In Vitro Techniques</topic><topic>Inhibitors</topic><topic>Metal–organic complexes</topic><topic>Models, Molecular</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Pyridines - chemical synthesis</topic><topic>Pyridines - chemistry</topic><topic>Pyridines - pharmacology</topic><topic>Spectrometry, Mass, Electrospray Ionization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lebon, Florence</creatorcontrib><creatorcontrib>Ledecq, Marie</creatorcontrib><creatorcontrib>Dieu, Marc</creatorcontrib><creatorcontrib>Demazy, Catherine</creatorcontrib><creatorcontrib>Remacle, José</creatorcontrib><creatorcontrib>Lapouyade, René</creatorcontrib><creatorcontrib>Kahn, Olivier</creatorcontrib><creatorcontrib>Durant, François</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of inorganic biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lebon, Florence</au><au>Ledecq, Marie</au><au>Dieu, Marc</au><au>Demazy, Catherine</au><au>Remacle, José</au><au>Lapouyade, René</au><au>Kahn, Olivier</au><au>Durant, François</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide</atitle><jtitle>Journal of inorganic biochemistry</jtitle><addtitle>J Inorg Biochem</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>86</volume><issue>2</issue><spage>547</spage><epage>554</epage><pages>547-554</pages><issn>0162-0134</issn><eissn>1873-3344</eissn><abstract>Previous investigations of the potential of metal–organic compounds as inhibitors of human immunodeficiency virus type I protease (HIV-1 PR) showed that the copper(II) complex diaqua [bis(2-pyridylcarbonyl)amido] copper(II) nitrate dihydrate and the complex bis[
N2-(2,3,6-trimethoxybenzyl)-4-2-pyridinecarboxamide] copper(II) behaved as inhibitors of HIV-1 PR. In a search for similar readily accessible ligands, we synthesised and studied the structural properties of
N2-(2-pyridylmethyl)-2-pyridinecarboxamide (L) copper(II) complexes. Three different crystal structures were obtained. Two were found to contain ligand L simultaneously in a tridentate and bidentate conformation [Cu(L
triL
bi)]. The other contained two symmetry-related ligands, coordinated through the pyridine nitrogen and the amide oxygen atoms [Cu(L
bi)
2]. A search of the Cambridge Structural Database indicated that L
tri resulting from nitrogen bound amide hydrogen metal substitution is favoured over chelation through the amide oxygen atom. In our case, we calculated that the conformation of L
tri is 11 kcal/mol more favourable than that of L
bi. ESI-MS experiments showed that the Cu(L
bi)
2 structure could not be observed in solution, while Cu(L
triL
bi)-related complexes were indeed present. The lack of protease inhibition of the pyridine carboxamide copper(II) complexes was explained by the fact that the Cu(L
biL
tri) complex could not fit into the HIV-1 active site.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11566326</pmid><doi>10.1016/S0162-0134(01)00219-7</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0162-0134 |
ispartof | Journal of inorganic biochemistry, 2001-09, Vol.86 (2), p.547-554 |
issn | 0162-0134 1873-3344 |
language | eng |
recordid | cdi_proquest_miscellaneous_71188438 |
source | ScienceDirect Freedom Collection |
subjects | Catalytic Domain Copper - chemistry Crystallography, X-Ray Drug Design ESI-MS HIV Protease - chemistry HIV Protease Inhibitors - chemical synthesis HIV Protease Inhibitors - chemistry HIV Protease Inhibitors - pharmacology HIV-1 PR In Vitro Techniques Inhibitors Metal–organic complexes Models, Molecular Organometallic Compounds - chemical synthesis Organometallic Compounds - chemistry Organometallic Compounds - pharmacology Pyridines - chemical synthesis Pyridines - chemistry Pyridines - pharmacology Spectrometry, Mass, Electrospray Ionization |
title | Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A14%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20structural%20analysis%20of%20the%20copper(II)%20complexes%20of%20N2-(2-pyridylmethyl)-2-pyridinecarboxamide&rft.jtitle=Journal%20of%20inorganic%20biochemistry&rft.au=Lebon,%20Florence&rft.date=2001-09-01&rft.volume=86&rft.issue=2&rft.spage=547&rft.epage=554&rft.pages=547-554&rft.issn=0162-0134&rft.eissn=1873-3344&rft_id=info:doi/10.1016/S0162-0134(01)00219-7&rft_dat=%3Cproquest_cross%3E71188438%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c361t-39164e634dc2d2c43795c59423368a8f40ec9b57d0b97e667f7a7b5b7e4dbe173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71188438&rft_id=info:pmid/11566326&rfr_iscdi=true |